i was please to read in the director's report the company is planning to concentrate on markets with established MAS markets.
I believe the somnodent is the best MAS on the market and they will be able to capture good market share quickly in countries that already use MAS.
sweden sounds like a country with gt potential for SOM growth
director's report good reading
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.010(3.13%) |
Mkt cap ! $66.99M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.0¢ | $34.11K | 106.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79696 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| SOM (ASX) Chart |